Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06019156
Other study ID # C2022-0044
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 13, 2022
Est. completion date February 10, 2023

Study information

Verified date August 2023
Source Hiroshima University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study explored whether exercise video distribution using metaverse space is effective in increasing physical activity among young people, along with mental health and locomotive function. This is a randomized parallel-group study. Participants will be assigned to 3 groups: a metaverse group, a YouTube group, and a control group. The metaverse group will receive eight 10-minute exercise videos each week with approximately 4 to 8 METs (metabolic equivalents of task) in the metaverse space to encourage exercise, and the YouTube group will receive access to the same exercise videos as the metaverse group. The control group was given no specific instructions. The intervention period was 8 weeks, and physical activity and other items were measured before and after the intervention. These pre- and post-intervention measurements will be used to determine whether the delivery of exercise videos via Metaverse is effective in increasing physical activity in young adults.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date February 10, 2023
Est. primary completion date December 11, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - individuals aged 18-30 at the time of obtaining consent - who owned a smartphone or computer and had internet access - who did not belong to an exercise community, such as a sports club Exclusion Criteria: - individuals who had a history of a disease that prohibited exercise - individuals whose physical activity was > 3000 metabolic equivalents of task (METs)/week - pregnant (or possibly pregnant) women

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise video distribution of Metaverse
Participants received a 10-minute exercise video each week with a load of about 4 to 8 metabolic equivalents of task (METs) in the metaverse space, for eight videos delivered to encourage exercise.
Exercise video distribution of YouTube
Participants view exercise videos with the same content as the metaverse group.

Locations

Country Name City State
Japan Hiroshima University Hiroshima

Sponsors (1)

Lead Sponsor Collaborator
Hiroshima University

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical activity The short form of the International Physical Activity Questionnaire Short Form was used to measure the effect of an intervention. The pre-measurement answered the most recent week, and the post-measurement responded to the next week after the 8 weeks intervention was finished.
Secondary Well-being The Japanese version of the World Health Organization Five-Well-Being Index was used. Pre- and post- 8 weeks intervention
Secondary Psychological distress The 6-item Kessler Scale as a nonspecific psychological distress scale was used. Pre- and post- 8 weeks intervention
Secondary Locomotive syndrome risk tests We used the 25-question geriatric locomotive function scale. Pre- and post- 8 weeks intervention
Secondary Social capital The social capital questions consisted of 11 items related to civic participation, social cohesion, and reciprocity, with a perfect score of 11 and higher scores indicating stronger social connections. Pre- and post- 8 weeks intervention
Secondary Quality of life (QOL) The Japanese version of the 26-item World Health Organization QOL measure was used to assess QOL. Pre- and post- 8 weeks intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1